Philippe Amouyel is Professor of Epidemiology and Public Health at the University Hospital of Lille in the North of France. He is in charge of a large academic research unit working on public health and molecular epidemiology of ageing diseases. A part of his research activity is devoted to cardiovascular diseases, understanding the multiple determinants of coronary artery disease and stroke. The other part is focused on the study of determinants, mainly genetic, of neurodegenerative diseases associated with cognitive decline and of Alzheimer’s disease in particular. He develops large epidemiological studies in population to attempt to decode the individual susceptibility to ageing diseases, using molecular techniques (high throughput genomics, transcriptomics, proteomics and bioinformatics…). Last September he published two new susceptibility genes for Alzheimer’s disease that offer new perspective for the understanding of this major threat. Since 2008 he is the CEO of the French National Research Foundation on Alzheimer’s disease and related disorders and chairs the Joint Programming Research Initiative on neurodegeneration and Alzheimer’s disease in particular associating 24 European countries.
Last Updated: Thursday 15 July 2010